Source:http://linkedlifedata.com/resource/pubmed/id/11306500
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
7
|
| pubmed:dateCreated |
2001-4-18
|
| pubmed:abstractText |
The alternative reading frame (ARF) tumor suppressor mediates growth arrest or apoptosis through activation of the p53 tumor suppressor. A prevailing concept is that ARF uses p21Cip1/Waf1, a p53-responsive gene and cyclin-dependent kinase (Cdk) inhibitor, to block cell cycle progression. Using p21 nullizygous cells, we demonstrate that p21 is nonessential for the antiproliferative activity of ARF and p53, although it likely governs the arrest through Cdk inactivation when present. ARF overexpression in p21-positive and p21-negative mouse embryo fibroblasts (MEFs), but not in primary cells lacking p53, induced a biphasic (G1 and G2) cell cycle arrest. The ARF-induced growth arrest, regardless of p21 status, coincided with activation of p53 and accumulation of hypophosphorylated retinoblastoma protein (retinoblastoma protein). In ARF-arrested p21-positive cells, the presence of growth-inhibitory retinoblastoma protein correlated with an absence of Cdk2-dependent kinase activity, an increase in p21 association with inactive Cdks, and a lack of cyclin A expression. In contrast, p21-/- mouse embryo fibroblasts were arrested by ARF despite containing elevated levels of cyclin A protein and highly active Cdk2-dependent kinases. These findings provide evidence that ARF can block growth through a p21-independent pathway(s) that overrides Cdk2 activation.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/CDKN1A protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Cdkn1a protein, mouse,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclin-Dependent Kinase Inhibitor...,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclin-Dependent Kinases,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclins,
http://linkedlifedata.com/resource/pubmed/chemical/Retinoblastoma Protein,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Suppressor Protein p53
|
| pubmed:status |
MEDLINE
|
| pubmed:month |
Apr
|
| pubmed:issn |
0008-5472
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:day |
1
|
| pubmed:volume |
61
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
3145-50
|
| pubmed:dateRevised |
2009-11-19
|
| pubmed:meshHeading |
pubmed-meshheading:11306500-3T3 Cells,
pubmed-meshheading:11306500-Alternative Splicing,
pubmed-meshheading:11306500-Animals,
pubmed-meshheading:11306500-Cell Division,
pubmed-meshheading:11306500-Cell Line,
pubmed-meshheading:11306500-Cyclin-Dependent Kinase Inhibitor p21,
pubmed-meshheading:11306500-Cyclin-Dependent Kinases,
pubmed-meshheading:11306500-Cyclins,
pubmed-meshheading:11306500-Enzyme Activation,
pubmed-meshheading:11306500-G1 Phase,
pubmed-meshheading:11306500-G2 Phase,
pubmed-meshheading:11306500-Genes, Tumor Suppressor,
pubmed-meshheading:11306500-Humans,
pubmed-meshheading:11306500-Mice,
pubmed-meshheading:11306500-Mice, Knockout,
pubmed-meshheading:11306500-Phenotype,
pubmed-meshheading:11306500-Phosphorylation,
pubmed-meshheading:11306500-Reading Frames,
pubmed-meshheading:11306500-Retinoblastoma Protein,
pubmed-meshheading:11306500-Tumor Suppressor Protein p53
|
| pubmed:year |
2001
|
| pubmed:articleTitle |
The alternative reading frame tumor suppressor inhibits growth through p21-dependent and p21-independent pathways.
|
| pubmed:affiliation |
Department of Pharmacology, The University of Iowa, College of Medicine, Iowa City 52242, USA.
|
| pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|